In Washington, D.C., the Biotechnology Innovation Organization responded to President Trump’s statement that he will “oppose anything that makes it harder for smaller, younger companies to take the risk of bringing their product to a vibrantly competitive market.” BIO, the world’s largest biotech trade association, is pleased to hear of the President’s support for entrepreneurial companies which make up most of BIO’s member companies.
BIO told BusinessWire “The ideas the President laid out in his meeting today–policies that would cut unnecessary regulation, enforce fair trade, increase competition, support small companies’ ability to attract capital and strengthen and promote market-based solutions–are ideas that BIO has been advocating for and working to build consensus on with others in the healthcare system.”